Back to Resources

Case Studies

Advancing Green Peptide Synthesis Through Optimized SPPS Solvent Usage

Integrating Drug Substance and Drug Product Development to Accelerate Clinical Timelines

Cysteine-Directed ADC Bioconjugation with Controlled DAR and Functional Validation

Comprehensive Bioanalytical Strategy for ADC Therapeutics

Obesity-Induced Sarcopenia: Translational Mouse Model for Muscle & Metabolic Therapies

From Challenge to Success: High-Purity Membrane Protein Production Across Multiple Classes

Developing a Reliable BCMA‑Expressing CHO‑K1 Cell Line to Accelerate the Discovery of Next‑Generation Cancer Therapeutics

Scalable Production of Unique Pseudoproline and Dmb Dipeptides for Efficient SPPS

Advancing Peptide Therapeutics Through Efficient Synthesis of Unnatural Amino Acids

Optimized SPR-Based Screening of RNA-Targeting Small Molecules

Enhancing Palatability in a Dual-API Oral Formulation for Canine Health

Strategic Optimization of Small Molecule Inhibitors for Enhanced Tumor Growth Inhibition

Transforming Biologics Manufacturing Through Smart Upstream Process Intensification

Enhancing Crystallization Control with In-Line PAT for Scalable Manufacturing

Exploring PROTAC Permeability: Comparative Insights Across Different Cell Lines

Reporter Cell Lines for Immuno-Oncology Drug Discovery: Targeting T-Cell Activation

Leveraging Surface Plasmon Resonance for Characterizing Ternary Complexes

Scalable Production of High-Purity Nanobodies Using Yeast Expression System

Redefine In silico Predictions with High-throughput LC-MS/MS LogD Analysis

Unravelling Immunological Depths: Exploring Oxazolone-induced Delayed-Type Hypersensitivity Model

Unlocking Insights: A Translational Mouse Model for Non-Genetic Heterotopic Ossification

A Preclinical Efficacy Study using Diet induced Obesity Mice Model

Designing an optimal and scalable protocol for formulating a 40% emulsifiable concentrate for a systemic insecticide

Developing a thermodynamically stable microemulsion with fine droplet size for delivering a highly lipophilic drug with limited intestinal permeability

Elevating Purity Levels: Racemizing Pharmaceutical Products in Advanced Flow Microreactors

Modelling Targeted Protein Degraders (TPDs) Utilizing Computational and Medicinal Chemistry Approaches

Flow Chemistry

A robust and scalable strategy to develop monodisperse Nanosuspension formulation for a poorly soluble drug substance

A robust and scalable strategy to develop amorphous solid dispersion formulation for a poorly soluble drug substance

Comprehensive Preclinical Development Program for a COVID mRNA Vaccine

Expression, in vivo Maturation and Tag-less Purification of a Recombinant Protein

An optimal upstream process development approach to increase the titers of the monoclonal antibodies (mAbs)